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Antimicrobial activities and mode of action  
of the selected novel thienopyrimidines derivatives 
2-[2-(diphenylmethylene) hydrazino]-5-isopropyl-
-3-methylthieno [2, 3-d] pyrimidin-4-one
Abstract
Background and purpose: Although thienopyrimidines have an im-
portant antimicrobial efficacy, there is still a lack of understanding their 
antimicrobial mode of action. The current study aims to assess the antimi-
crobial activity of newly synthesized thienopyrimidines derivatives against 
some pathogens and to determine the mode of action of the most potent 
compound 2-[2-(diphenylmethylene) hydrazino]-5-isopropyl-3-methylthie-
no [2, 3-d] pyrimidin-4-one (compound no. 20).
Materials and methods: Newly synthesized thieno[2,3-d]pyrimidin-
ediones compounds examined for antimicrobial activity against pathogenic 
organisms by cut plug and viable cell counting method. The minimum in-
hibitory concentration (MIC) of (compound no. 20), it’s mode of action; 
cytotoxicity and LC50 were determined.
Results: One compound, compound no. 20 displayed potent activity. 
The growth inhibitory effect (M/C) of the compound no. 20 differed among 
the tested strains. The inhibition becomes stronger; Candida albicans> 
Escherichia coli> Staphylococcus aureus. The MIC for all the tested mi-
croorganisms was > 50 <100 μg/mL. E. coli and C. albicans recorded 
highest value of potassium flow. Compound no. 20 affects oxygen consump-
tion and exhibited cytotoxicity against E. coli. LC50 value with brine 
shrimps was estimated at 48.736 μg/mL concentration. 
Conclusion: It could be concluded that the mode of action of compound 
no.20 may be due to disruption of the cytoplasmic membrane by action upon 
the membrane potentials, permeability or net surface charge of the micro-
bial membranes by its physicochemical characteristic. This led to leakage of 
cellular components and eventually cell death. This will lead to improved 
antimicrobial formulations and to ensure the prevention of the emergence 
of microbial resistance.
IntroductIon
Recently, the problems of environmental pollution and health at-tracted considerable attention. The increasing appearance of resis-
tant strain of pathogenic bacteria to the classical antimicrobial agents is 
rapidly represents an alarming threat to public health. The most com-
monly encountered antibiotic-resistant bacteria, methicillin-resistant S. 
aureus (MRSA), vancomycin-resistant Enterococci (VRE), and penicillin 
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and cephalosporin-resistant Streptococci has had a major 
impact on infections in both the hospital and commu-
nity setting (1). Thus, there is a pressing need for new ef-
ficacious antimicrobial agents that are capable of treating 
resistant bacterial strains.
Thienopyrimidines occupy a special position among 
fused pyrimidines compounds because they play an im-
portant role in diverse biological activities (2). A number 
of derivatives of these compounds display therapeutic ac-
tivity as antimicrobial (3, 4), anti-inflammatory (5), an-
algesic activities (6), inhibition of cancer cell proliferation 
(7), antidiabetic (8) and prevention of cartilage destruc-
tion in particular diseases (6). Consequently, thienopy-
rimidines occupy a special position among these com-
pounds. Thienopyrimidine derivatives are the one of 
outcome of the research in the field of therapeutic activ-
ity as antimicrobial (9). They are structural analogs of 
biogenic purines and can be considered as potential nu-
cleic acid antimetabolites (10, 2).
In spite of the enormous antimicrobial activity of thi-
enopyrimidines compounds and their derivatives that have 
been discovered, the mechanisms of action of these com-
pounds are not yet reported (1). According to the reports 
of antimicrobial activity for structurally unrelated thieno-
pyrimidinones, the biocides and antibiotics have multiple 
target sites within the microbial cell and the overall damage 
to these target sites results in the bactericidal effect. Since 
the emergence of bacterial resistance to biocides or antibi-
otics and the suggestion that biocide and antibiotic resis-
tance in bacteria might be linked, it became an important 
issue to understanding the mechanism(s) of action of a 
biocide (11). Consequently we can consider the biocide and 
antibiotic mechanism(s) of action as a guide to understand 
the mechanism of action of thienopyrimidines com-
pounds. Therefore, according to the bacterial structure; the 
overall mechanism(s) of action of any antimicrobial agents 
may be defined. Thus, there is three levels of interaction 
can be described: 1-interaction with outer cellular compo-
nents; 2-interaction with the cytoplasmic membrane and 
3-interactionwith cytoplasmic constituents. Despite this, 
a biocide acts at one or all three levels of interaction with 
the bacterial cells to produce its antimicrobial activity (11).
The objective of this work was to study the antimicro-
bial activity of some newly synthesized thienopyrimidines 
derivatives and to investigate the mode of action of the most 
effective one, the compound no. 20 against Gram-positive, 
Gram-negative bacteria and pathogenic fungal species.
MaterIals and Methods
synthesis of the thienopyrimidine 
derivatives compounds
The thienopyrimidine derivatives compounds were syn-
thesized and kindly given by Prof. Hamedet et al. (12) 
(Chemistry Department, Faculty of Science, Menoufiya 
University, Egypt). The thienopyrimidine molecular for-
mu la was C6H4N2S. The procedures of the synthesis of these 
compounds were described in details by Hamedet al. (12). 
The chemical structure of the most potent derivative com-
pound no. 20 was 2-[2-(diphenylmethylene) hydrazino]-5-
isopropyl-3-methylthieno [2, 3-d] pyrimidin-4-one. Its 
molecular formula was (C23H22N4OS) as shown in Fig.1.
antimicrobial screening
All the test organisms were obtained from the culture 
collection of the Microbiological Resource Center 
(MIRCEN), Faculty of Agriculture, Ain-Shams Univer-
sity, Cairo, Egypt.
antibacterial activity
Two bacterial species represent both Gram-positive 
and Gram-negative strains were used to test the antibacte-
rial activities of the target compounds: S. aureus as repre-
sentative for the Gram-positive strains, while the Gram-
negative strain was represented by E. coli. The bacteria 
were maintained on nutrient agar slopes.
antifungal activity
Two pathogenic fungal species were used in the present 
study: Fusarium oxysporum and C. albicans. The fungi 
were obtained on czapek's Dox and sabouroud agar 
slopes, respectively.
the agar diffusion method
The antibacterial and antifungal activities of the syn-
thesized compounds were screened against the following 
bacterial strains: S. aureus as representative for the Gram-
positive strains, while the Gram-negative strain was repre-
sented by E. coli and the following fungi: F. oxysporum and 
C. Albicans using the agar diffusion method (13). It was 
used to determine the antimicrobial activities of the pre-
pared eleven thienopyrimidine compounds as described by 
El-Sayed et al. (2). The assay medium flasks containing 50 
mL of media for each test organism. They were allowed to 
reach 40 to 50 °C to be inoculated with 0.5 mL of the test 
organism cell suspension. The flasks were mixed well and 
poured each into a Petri dish (nine cm) and allowed to 
Figure 1. Structural formula of 2-[2-(diphenylmethylene) hydra-
zino]-5-isopropyl-3-methylthieno [2, 3-d] pyrimidin-4-one (com-
pound no. 20).
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solidify. After solidification, holes (0.5 cm in diameter) 
were made in the agar plate by a sterile cork poorer. The 
solutions of synthesized target compounds were prepared 
by dissolving 20 mg of each compound in two mL DMSO 
(Dimethyl sulfoxide). In these holes, 100 μL of each com-
pound was placed using an automatic micropipette. The 
Petri dishes were left at 5 °C for one hour to allow diffusion 
of the samples through the agar medium and retard the 
growth of the test organism. Plates were incubated at 30 °C 
for 24 h for bacteria and 72 h of incubation at 28 °C for 
fungi. The antibiotic ampicillin trihydrate and the antifun-
gal drug clotrimazole (Canasten) were used as positive 
controls, while DMSO was used as negative control. The 
diameters of inhibition zone were measured. The com-
pounds which produced highest inhibition zone were fur-
ther assayed at different concentrations in DMSO in order 
to quantify its inhibitory effect.
Minimal inhibitory concentration (MIc)
The minimum inhibitory concentration (MIC) is „the 
lowest concentration of an antimicrobial that prevents the 
visible growth of a microorganism after overnight incuba-
tion”. The importance of the MIC test is that it contains a 
semi-quantitative process which gives an approximation to 
the least concentration of antimicrobial agent needed to 
prevent microbial growth. The compound no. 20 showing 
reasonable inhibition zones (≥ 20mm) were subjected to 
determine their minimal MIC value using the twofold se-
rial dilution method recommended by the Clinical and 
Laboratory Standards Institute (14). The test organisms 
were grown in their suitable nutrient broth medium for 
bacteria and sabouraud’s medium for fungi at 30 °C for 
24 h for bacteria and 48 h at 28 °C for fungi. Two fold 
serial dilutions of the test compound no.20 were prepared 
using the proper nutrient broth to obtain concentrations 
100, 50, 25 and 12.5 μg/mL. The broth tubes were seeded 
with the test bacteria (6 x 104) CFU/mL and (8 x 102) 
spores/mL for the test fungi. The incubation period was for 
24 h at 30 °C for bacteria and 96 h at 28 °C for fungi.
The growth was measured with the spread-plate (viable 
cell counting) method. After 24 h of contact, one mL 
portions were removed and mixed with nine mL of the 
full-strength nutrient broth; then, decimal serial dilutions 
were prepared from these dilutions, and the surviving 
bacteria or fungi were counted by the spread-plate meth-
od. After inoculation, the plates were incubated at 30 °C 
and the number of colonies was counted after 24 h for 
bacteria and after 48 h for fungi at 28 °C. The ratio of the 
colony numbers for the media containing the compound 
no. 20 and those without this compound (M/C) was 
taken as the surviving cell number, and with this value, 
the antimicrobial activity was evaluated (15).
leakage of potassium (K+)
Leakage of potassium was assayed as a mean to study 
membrane damage caused by the compound no. 20 as 
described by Strauch et al. (16). The two tested bacterial 
species grown in nutrient broth medium at 30 °C for 24 
h. and the tested fungi grown in the broth sabouraud’s 
medium at 28 °C for 96 h. The cells of the test organisms 
were collected during exponential phase of growth by 
centrifugation, washed three times with 0.9% (wt. /vol) 
NaCl and finally resuspended in 20 mL of the same solu-
tion. The compound no. 20 was added at sublethal dose 
concentration (50 μg/mL) to aliquots of the cultures and 
shake for 30 min. Samples (five mL) were taken and 
centrifuged immediately at 6000 g, and the supernatants 
were frozen. K+ concentration was determined using a 
flame photometer (clinical flame photometer 410). Neg-
ative control sample was not treated with the compound 
no.20.
respiratory activity
The quantity of oxygen consumed by the living cells 
(respiratory activity) in the presence or absence of the sub-
lethal dose of the thienopyrimidine compound was deter-
mined as described by Tapia et al. (17). The living cells of 
the tested bacterial species and fungi grown up to expo-
nential phase were harvested by centrifugation (6000 g), 
washed with saline solution and resuspended to a concen-
tration of one mg/mL cells (wet weight) in 50 mM phos-
phate buffer (pH 7.0).The cell suspension was added to a 
two mL chamber. The chamber then closed and incu-
bated for five min. at room temperature with sublethal 
dose (50 μg/mL) of the compound no.20. Cell suspension 
without the sublethal dose of compound no.20 was used 
as control. The oxygen consumption was measured po-
larographically with oxygraph (Yellow Spring Instru-
ment, Yellow Spring, OH, U.S.A.). The quantity of oxy-
gen was determined as μmol of oxygen/mg wt. /h (18).
In Vitro cytotoxicity of the compound 
no.20 against E. coli
The cytotoxicity of the compound no.20 was detected 
using the biochemical induction assay (BIA).The bio-
chemical induction assay (BIA) is a bacterial test system 
specifically responsive to agents that directly or indirectly 
initiate DNA-damage. The BIA uses an E. coli strain, in 
which the lacZ gene encodes b-galactosidase (LacZ).
When the culture is treated with a DNA-damaging agent, 
the enzyme b-galactosidase is detected by a suitable chro-
mogenic substrate (19).
In this test a plate containing 10 mL of nutrient agar 
was seeded by E. coli BR 315 and incubated at 30 °C for 
two days. The plates were spotted with sublethal dose (50 
μg/mL) of the compound no.20. After three hours of in-
cubation the plate is overlaid with a chromogenic sub-
strate (a layer of agar containing 6-bromo-2-naphtyl b-D-
galactopyranoside). The production of red color around 
the test compound is used as an indication of DNA-dam-
aging activity.
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effect of the compound no.20 on cell 
morphology of E. coli
The test organism E. coli was treated with the sub-
lethal dose (50 μg/mL) of the compound no.20. The mor-
phology of E. coli was examined microscopically after 
being incubated for 24 h. at 30 °C (20).
lc50 determination of compound no.20
LC50 is the lethal concentration required to kill 50% 
of the population. This bioassay involves subjecting three 
replicate groups of individuals to a range of concentra-
tions (or doses) of a toxic compound and measuring the 
mortality after a defined time interval. The data are then 
plotted and the LC50 is interpolated from the graph. 
Brine shrimps (Artemia salina) lethality bioassay was used 
to determine the LC50 of compound no.20 according to 
the procedures described by (21, 22). The advantages of 
this method are being rapid results, reliability, inexpen-
sive and convenient assay (21). Brine shrimps were hatch-
ed using brine shrimp eggs in a shallow rectangular dish 
filled with sea water(prepared using sea salt 38 g/L and 
adjusted to pH 8.5 using 1N NaOH) under constant 
aeration. A plastic divider with several two mm holes was 
clamped in the middle of the dish to make two unequal 
compartments. The shrimp eggs were sprinkled into the 
larger compartment which was darkened while the small-
er compartment was illuminated. After 48 h the photo-
tropic hatching, active nauplii free from egg shells were 
collected from the illuminated compartment and used 
for the assay.
Stock solution of the compound no.20 were prepared 
by dissolving 20 mg of it in two mL of DMSO. Four 
diff erent concentrations namely 10, 25, 50 and 100 μg/mL, 
were prepared in triplicate from the stock solution. 0.5 mL 
of each concentration was added to vials each containing 
4.5 mL of brine solution. Thirty nauplii (larva) were 
transferred through a glass capillary and placed in each 
vial. A control was prepared for the compound being 
assayed by adding 4.5 mL of sea water and 0.5 mL of 
DMSO. The shrimps that survived were counted after 24 
hours. The total death and percentage mortality (death) 
at each dose level and control were determined. The 
LC50value was calculated using the MS Excel 2007 to 
find regression equation (Y=mortality; X=concentra-
tions). The LC50 was derived from the best-fit line ob-
tained (23).
effect of the compound no.20 on the 
total protein of the tested organisms
The effect of the compound no.20 on total proteins of 
the tested organisms was determined using the method 
described by Lowery et al. (24). The molecular weight of 
C. albicans, E. coli and S. aureus protein were determined 
using SDS-polyacrylamide gel electrophoresis according 
to Laemmli (25).
statistical analysis
The data were analyzed for statistical significance using 
analysis of variance (ANOVA) least significant difference 
(L.S.D) test at P value 0.05 (26). All the experiments were 
carried out in triplicate otherwise it will be indicated
results
the antimicrobial activity of the tested 
thienopyrimidine compounds
The obtained results in Table 1 suggested that the an-
timicrobial activities of the eleven tested compounds 
showed normal and mild activity in comparison to the 
reference drugs ampicillin trihydrate and the antifungal 
drug clotrimazole (Canasten). From the eleven prepared 
thienopyrimidine compounds, the compound no.20 was 
the most effective one on Gram negative, Gram positive 
bacteria and C. albicans. The diameter of inhibition zones 
produced by it ranged from 20 to 25mm after 48h of 
incubation for bacteria and 96h for fungi. None of the 
eleven prepared thienopyrimidine compounds affect F. 
oxysporum.
Minimal inhibitory concentration (MIc)
The MIC of the compound no.20 result was illustrat-
ed in Fig.2. They showed that the inhibitory effect in-
creased significantly by increasing in the concentration of 
Figure 2. The antimicrobial activity evaluated by surviving cell 
numbers at different concentration of the compound no.20
M: The colony numbers for the media containing the compound 
no.20, C: The colony numbers for the media without the compound 
no.20. E. coli: Escherichia coli, S. aureus: Staphyloccous aureus, 
C. albicans: Candida albicans
Antimicrobial activities and mode of action of thienopyrimidines Nadia H. El-Batanony
Period biol, Vol 119, No 1, 2017. 31
the compound no.20. The test organisms was failed to 
grow completely with100 μg/mL concentration. Figure 2 
proved that the MIC for all the tested microorganisms 
was >50<100 μg/mL. The growth inhibiting effect was 
quantitatively determined by ratio (M/C) of the surviving 
cell number, (M) in the medium containing the com-
pound no.20 to that without it (C). As shown in Fig.2, 
the growth inhibitory effect of the compound no.20 dif-
fered among the bacterial strains. The inhibition becomes 
stronger in (decreasing order) C. albicans>E.coli>S. aureus.
leakage of potassium (K)
The effect of the compound no.20 upon the mem-
branes of S. aureus, E. coli and C. albicans as indicated by 
potassium (K+) leakage is shown in Fig. 3. This figure 
indicated that compound no.20 has significant observable 
and marked leakage effects upon the tested organisms at 
30 min. The highest value of potassium flow was record-
ed with E. coli and C. albicans, whereas the least flow was 
noticed with S. aureus. The results with the Gram- nega-
tive organism showed that the compound no.20 released 
higher amounts of potassium ion than in the Gram- pos-
itive organism.
respiratory activity
Figure 4. showed that the respiratory activity of E. coli, 
S. aureus and C. albicans cells treated or untreated with 
the tested compound no.20 was evaluated. The com-
pound no. 20 at the sublethal dose has almost no effect 
on S. aureus cells respiration where it gives values compa-
rable to the control. However with E. coli and C. albicans 
the sublethal dose of compound no.20 increased signifi-
cantly the respiratory activity to somehow as shown in 
Fig. 4 in comparable to the control.
Table 1. The inhibitory effect of the tested thinopyrimidine compounds against different test bacteria on nutrient agar at 30 °C for 24 h and 
fungi on sabouroud agar at 28 °C for 96h by the cut plugs method.
Thinopyrimidine compounds Diameter of inhibition zones (mm)
Tested organisms
E. coli S. aureus C. albicans F. oxysporium
3 nil nil nil nil
4 12 12 ± 0.5 nil nil
5 nil nil nil nil
7a 6 ± 0.4 6 ±0.5 nil nil
8 nil nil nil nil
9 12 ± 0.2 12 ± 0.3 nil nil
10a-h nil nil nil nil
11a-h nil nil nil nil
12a nil nil nil nil
14a nil nil nil nil
20 20± 0.3 25 ± 0.2 20 ± 0.2 nil
22a-d nil nil nil nil
Ampicillin trihydrate 20±0.3 22± 0.3 Not tested Not tested
Clotrimazole Not tested Not tested 20 + 0.2 18
DMSO nil nil nil nil
E.coli: Escherichia coli, S. aureus: Staphyloccous aureus, C. albicans: Candida albicans, F. oxysporium: Fusarium oxysporium. Ampicillin trihydrate: anti-
bacterial drug, Clotrimazole: antifungal drug. Nil: negative result (no inhibition). ±: standard deviation of the means. DMSO: Dimethyl sulfoxide.
Figure 3. The amount of potassium released under the effect of the 
compound no.20
Control: Sample was not treated with the compound no.20, Treat-
ed cells: Cells treated with the compound no.20 at concentration 
50 μg/mL (sublethal dose). PPm: Part per million. The results are 
the mean ± SD (n = 3). Means with the same letter are not sig-
nificantly different.
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In vitro cytotoxicity of the compound 
no.20 against E. coli
The compound no.20 showed some cytotoxicity against 
DNA genome of E. coli, where it gives a brown color (pos-
itive result) indicating the hydrolysis of 6-bromo2-naph-
thyl-b-galactopyranoside by b-galactosidase enzyme.
effect of the compound no.20 on cell 
morphology of E. coli
It was showed that the compound no.20 affect E. coli 
cell morphology, which was manifested as elongation and 
swollen of E. coli cells as shown in Fig.5.
lc50 determination of the compound 
no.20
The procedure determines LC50 value in μg/ mL of the 
most effective compound no. 20 in the brine medium. 
The activity of the compound no.20 was manifested as 
toxic agent to shrimps. Figure 6 gave the cytotoxicity re-
sults for the compound no.20. In Fig.6 the result of re-
gression analysis indicated that the mortality rate (Y) is 
Figure 4. The amount of oxygen consumed by the tested microorgan-
isms under the effect of the compound no.20.
Control: Sample was not treated with the compound no.20, Treat-
ed cells: cells treated with the compound no.20 at concentration 50 
μg/mL (sublethal dose). The results are the mean ± SD (n = 3). 
Means with the same letter are not significantly different.
Figure 5. Effect of the compound no.20 on cell morphology of E. coli 
cells stained with gram stain and grown in nutrient broth with 
sublethal dose (50 μg/mL) under Light microscopy (1000x).
(A): Zero μg/mL, (B): 50 μg/mL (sublethal dose).
Figure 6. Mortality percentage (%) curve of Brine shrimps (Artemia 
salina) nauplii exposed to different the compound no.20 concentra-
tions for 24 h.
Figure 7. Effect of the compound no.20 on the total protein content 
(mg/mL) of the tested organisms.
Control: Sample was not treated with the compound no.20, Treat-
ed cells: cells treated with the compound no.20 at concentration 50 
μg/mL (sublethal dose). The results are the mean ± SD (n = 3). 
Means with the same letter are not significantly different.
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positively correlated the concentration (X) having a re-
gression coefficient (R) close to one. The number of dead 
shrimps increased in response to increase in the com-
pound no.20 concentrations. An LC50 value of the com-
pound no. 20 for brine shrimps was estimated at 48.736 
μg/mL concentration from the regression equation.
effect of the compound no.20 on  
the total protein of the tested organisms
The amount of the total protein of E. coli, S. aureus and 
C. albicans cells treated with the compound no. 20 were 
decreased as compared with control as shown in Fig.7. Gel 
electrophoresis of the total protein indicated that there is a 
difference in protein banding pattern at 205-116 KDa in 
E. coli and also at 97 KDa in S. aureus as compared with 
untreated cells. However, there is no difference in protein 
banding pattern in C.albicans treated with the compound 
no. 20 compared with untreated cells as shown in Fig.8.
dIscussIon
the antimicrobial activity of the tested 
thienopyrimidine compounds
Although, thieno[2,3-d]pyrimidines had been exten-
sively explored for their varied biological activity, the com-
pounds reported here had not yet been prepared in previ-
ous literature. In this paper, the compound no.20 possess 
abroad spectrum of antimicrobial activities. These results 
agreed with that obtained by many researchers (27,3,28).
The results indicated that thienopyrimidines are interest-
ing heterocyclic compounds and a number of derivatives 
of these compounds display therapeutic activity as anti-
bacterial and antifungal agents (5,1,29,9).
Minimal inhibitory concentration (MIc)
The MIC of the compound no.20 for all the tested 
microorganisms was >50 <100 μg/mL. Other researchers 
found that cyclopenteno and cyclohexeno [b]thieno[2,3-
d]-3,4-dihydropyrimidine-4-one displayed reasonable 
activity (MIC values 6.25-25 mg/L) against both Gram-
positive and Gram-negative bacteria (30,1). Chambhare 
et al. (3), proved that furanyl-thieno[2,3-d]pyrimidin-4-
ones displayed MIC values in the range of 4-100 mg/L 
against a collection of Gram-positive and Gram-negative 
microbe. Some novel thienopyrimidine and triazolo-
thienopyrimidines showed MIC values in the range of 
11- 512 μg/mL (6). As well as, they also displayed antimi-
crobial activates towards the test organisms (Pseudomonas 
aeruginosa, S. aureus, Bacillus subtilis, E. coli, C. albicans 
and C. parapsilosis).It is obvious that the MIC depends 
mainly on the tested compound as well as used organisms. 
The growth inhibiting effect (M/C) obtained by Kenawy 
et al. (31) coincide with that of the compound no.20 in 
this study. They found that the growth inhibitory effect 
M/C of polymer IX became stronger in the order of B. 
subtilis<E. coli <P. aeruginosa< a fungus (Trichophyton ru-
brum). Hence, the novel compound no.20 is considered 
as potent antibacterial agent (2, 32, 33).
leakage of potassium (K)
The treatment of Gram- negative and positive bacteria 
with the compound no.20 at sublethal dose lead to release 
of higher amounts of potassium ion with the Gram- neg-
ative than the Gram- positive organism. Marked leakage 
of cytoplasmic material is considered indicative of gross 
and irreversible damaged to the cytoplasmic membrane 
(34).
respiratory activity
The effect of the compound no.20 on bacterial respira-
tion was similar to that recorded with nisin on E. coli and 
S. aureus (35). Poly (chlorethyvinylether-co-vinylbenzoyl-
chloride) increased respiration for C. albicans and C. 
tropicials (20) as that observed with the effect of the com-
pound no.20 on C. albicans respiration. This effect may 
be indicates that many chemical compounds interfering 
directly with electron transfer or uncoupled oxidative 
phosphorylation from electron transport. So, the aerobic 
synthesis of ATP is inhibited and the oxygen uptake is not 
inhibited (17). Also, it may be indicates a slight effect on 
Figure 8. Protein banding patterns of tested organisms under the 
effect of the compound no.20 at 50 μg/mL at 10% SDS- Polyacryl-
amide gel electrophoresis.
Lanes: M: high molecular weight mass protein standard, 1: Protein 
pattern of untreated E. coli (control), 2: Protein pattern of E. coli 
treated with the compound no.20, 3: Protein pattern of untreated 
S. aureus (control), 4: Protein pattern of S. aureus treated with the 
compound no.20, 5: Protein pattern of untreated C. albicans (con-
trol) and 6: Protein pattern of C. ablicans treated with the com-
pound no.20.
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the plasma membrane and increasing cells respiration for 
exhausting the energy compound present inside the cell 
before its death (20).
In Vitro cytotoxicity of the compound 
no.20 against E. coli
The cytotoxic effect of the compound no.20 against E. 
coli coincide with that obtained by (11). They observed that 
the cytoplasmic membrane disruption is often exempli-
fied by the leakage of intracellular components, potassium 
(K+) followed by inorganic phosphates, pool of amino 
acids and materials absorbing at 260 nm, nucleic acids 
and proteins. Moreover, the compound no.20 changed 
cell morphology in E. coli cells. Saloman and Farias (36) 
found that microcin 25; a peptide antibiotic caused E. coli 
cell filamentation. Moreover, poly (methyl methacrylate 
co-vinylbenzoylchloride) altered cell morphology which 
was manifested as aggregated and swollen yeast cells (C. 
albicans ATTCC 2091) (20). Simõesc et al. (18) found 
that interference on bacterial cell cycle occurs at high 
ortho-phtalaldehyde concentrations and cell division is 
compromised as the cellular septation seems not to occur. 
Therefore, a cellular elongation takes place in P. fluorescens 
cells. Consequently, the formation of long forms of bac-
teria following antimicrobial treatment may be an indica-
tion of cell wall damage (11).
lc50 determination of the compound 
no.20
Compound no.20 is manifested as toxic agent to brine 
shrimps. The result of LC50 value of the compound no.20 
for brine shrimps coincides with many other studies. The 
LD50 values of the active compound of a series of 2-substi-
tuted amino-3-aminocyclopenteno or cyclohexeno[b]
thieno[2,3-d]-3,4-dihydropyrimidin-4-ones ranged from 
25-250 μg/mL (30). The cytotoxicity activity of the polar 
fractions of Cochlospermum tinctorium extracts using the 
brine shrimp lethality bioassay method were determined by 
linear regression analysis method and it was 240μg/ mL for 
80 % acetone extract and 437μg/mL for n-butanol extract 
(37). The compound no.20 showed potent biocide activity 
against brine shrimp due to their lower cytotoxicity that 
agreement with preliminary anti-microbial screening and 
the minimum inhibitory concentration (MIC). This find-
ing is in agreement with that of Fayed and Ghanem (29).
effect of the compound no.20 on the 
total protein of the tested organisms
The result obtained was in agreement with that ob-
tained by Ali et al. (38). They found that treatments of 
MCF-7 cells with 1/10 of LC50 of three thienopyrimidine 
derivatives decline the total protein, DNA and RNA con-
tent compared with MCF-7 cells harvested from control.
The protein banding pattern of E. coli and S. aureus 
treated cells with the compound no.20, give results agreed 
with many researchers (39, 40). They found that thieno-
pyrimidine derivatives inhibits dihydrofolate reductase 
(DHFR) which plays an essential role in carbon metabo-
lism, which is critical to the biosynthesis of DNA, RNA, 
and the essential amino acid methionine. However, the 
effect of the compound no.20 on protein banding pattern 
in C. albicans coincide with that obtained with Mahmoud 
and Aly (20). They found that the effect of synthesized 
polymers modified poly (methylmethacrylate-co-vinyl-
benzoylchloride) and a modified linear poly (chloroeth-
ylvinylether-co-vinylbenzoylchloride) on C. albicans indi-
cated no clear effects in the phosphopeptidomannan 
molecular weight with main bands at 45, 25 and 15 kDa. 
The only differences were in the protein concentrations.
Conclusion: it could be concluded that the compound 
no.20 has antimicrobial activity and cytotoxicity against 
the tested organisms. Moreover, the present results lead us 
to speculate that the compound no.20 antimicrobial 
mode of action may be due to disruption of the cytoplas-
mic membrane which is often exemplified by the leakage 
of intracellular components, potassium (K+) followed by 
pool of amino acids and materials absorbing at 260 nm, 
nucleic acids and proteins. It is generally accepted that the 
bacterial outer envelope is responsible for the different 
microbial responses to biocidal challenges (11). Active 
agent can induce damage to the cytoplasmic membrane 
by action upon the membrane potentials, bound enzymes 
or permeability and this lead to leakage potassium ion, 
and other cellular components and eventually cell death 
(41, 42, 43). Furthermore, anther speculation of mode of 
action is that, the physicochemical characteristic of the 
compound no.20 may be match with lipid composition 
and net surface charge of the bacterial membranes. There-
fore, this cause its penetration and membrane leakage 
subsequently, this process can change the morphology of 
the bacterial cell (34). Thus, the ultimate goal of study the 
mechanisms of action of antimicrobial compounds will 
help to improve the bactericidal activity of a product, to 
confirm that biocides are employed in the most advanta-
geous manner and to ensure the prevention of the emer-
gence of microbial resistance. Furthermore, understand-
ing the target sites of the antimicrobial compounds will 
lead to improved antimicrobial formulations (11, 1).
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